Skip to main content
. 2021 Nov 1;11:748698. doi: 10.3389/fonc.2021.748698

Table 5.

Pathway enrichment of gene expression correlating positively with glyoxalase 1 expression in tumor cell lines of the CCLE.

Pathway Count Fold enrichment FDR Genes
Spliceosome 20 7.0 3.4 × 10−9 CDC5L, HNRNPA1, HNRNPA3, HNRNPC, HNRNPK, LSM2, LSM3, LSM5, MAGOH, MAGOHB, PPIL1, PRPF4, RBMXL1, SNRNP40, SNRPB, SNRPC, SNRPD1, SNRPE, SNRPG, SRSF3
RNA transport 22 6.0 3.4 × 10−9 DDX20, EIF1AX, EIF2S1, EIF4E, GEMIN5, GEMIN6, KPNB1, MAGOH, MAGOHB, NDC1, NUP35, NUP37, NUP43, NUP54, NUP107, NUP153, NUP155, RPP40, SUMO1, SUMO2, XPO1, XPO5
Cell cycle 19 7.2 3.4 × 10−9 CCNB1, CCNB2, CCNE2, CDC25C, CDC27, CDC7, CDK1, DBF4, HDAC2, MAD2L1, MCM3, ORC2, ORC3, ORC4, PTTG1, SKP1, SKP2, PRIM2, TTK
DNA replication 10 12.7 1.2 × 10−6 DNA2, MCM3, POLA1, POLE2, PRIM2, RFC2, RFC3, RFC4, RFC5, RPA2
Proteasome 6 6.4 0.037 PSMD12, PSMA4, PSMD14, PSMB3, PSMC1, PSMB1

Pathway enrichment analysis was performed for 340 genes correlating positively with Glo1 RNA copy number in the CCLE database with r2 ≥ 0.1 using the KEGG database; data from 1,010 tumor cell lines for 10,758 genes, applying a Bonferroni correction of 10,758 ( Supplementary Table S12 ). Statistical threshold criterion was FDR <0.05. Genes unrecognized in KEGG were pseudogene (2), antisense RNA (7), microRNA (2), long noncoding RNA (4), other intronic RNA (1), and uncharacterized proteins (1). Genes highlighted in bold are those encoding for proteins that were decreased in the early-stage proteomic response to MG-induced cytotoxicity.